Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 22, 2014
Personalized oncology: genomic screening in phase 1Ida Viller Tuxen, Lars Jønson, Eric Santoni-Rugiu, et al.
British Journal of Cancer|June 13, 2019
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patientsIda Viller Tuxen, Lise Barlebo Ahlborn, Morten Mau-Soerensen, et al.
Oncotarget|September 18, 2018
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumorsLise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2018
Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I TrialsIda Viller Tuxen, Kristoffer Staal Rohrberg, Olga Oestrup, et al.
NPJ Genomic Medicine|July 3, 2019
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancerBirgitte Bertelsen, Ida Viller Tuxen, Christina Westmose Yde, et al.
BMC Cancer|August 7, 2025
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid TumorsKristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, et al.
Pageof 1